tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
Germany Market

Vertex Pharmaceuticals (VX1) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Vertex Pharmaceuticals’s (VX1) Moving Averages Convergence Divergence (MACD) indicator is 4.41, suggesting Vertex Pharmaceuticals is a Sell.
Vertex Pharmaceuticals’s (VX1) 20-Day exponential moving average is 405.73, while Vertex Pharmaceuticals’s (VX1) share price is €409.7, making it a Buy.
Vertex Pharmaceuticals’s (VX1) 50-Day exponential moving average is 397.55, while Vertex Pharmaceuticals’s (VX1) share price is €409.7, making it a Buy.

Vertex Pharmaceuticals (VX1) Pivot Points

Mar 05, 2026, 11:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
392.40
399.90
403.65
411.15
414.90
422.40
426.15
Fibonacci
399.90
404.20
406.85
411.15
415.45
418.10
422.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vertex Pharmaceuticals (VX1) Moving Averages

Mar 05, 2026, 11:17 PM
Period
Simple
Exponential
MA5
410.79Sell
410.31Sell
MA10
409.30Buy
409.04Buy
MA20
404.49Buy
405.73Buy
MA50
397.80Buy
397.55Buy
MA100
384.25Buy
388.95Buy
MA200
375.01Buy
390.15Buy
Vertex Pharmaceuticals’s (VX1) 10-Day exponential moving average is 409.04, while Vertex Pharmaceuticals’s (VX1) share price is €409.7, making it a Buy.
Vertex Pharmaceuticals’s (VX1) 100-Day exponential moving average is 388.95, while Vertex Pharmaceuticals’s (VX1) share price is €409.7, making it a Buy.
Vertex Pharmaceuticals’s (VX1) stock price is €409.7 and Vertex Pharmaceuticals’s (VX1) 50-day simple moving average is 397.80, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) stock price is €409.7 and Vertex Pharmaceuticals’s (VX1) 100-day simple moving average is 384.25, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) stock price is €409.7 and Vertex Pharmaceuticals’s (VX1) 200-day simple moving average is 375.01, creating a Buy signal.

Vertex Pharmaceuticals (VX1) Technical Indicators

Mar 05, 2026, 11:17 PM
Name
Value
Implied Action
RSI (14)
54.01
Neutral
STOCH (9,6)
46.12
Neutral
STOCHRSI (14)
61.29
Neutral
MACD (12,26)
4.41
Sell
ADX (14)
13.81
Buy
Williams %R
-42.49
Buy
CCI (14)
41.07
Neutral
ATR (14)
9.07
-
Ultimate Oscillator
51.32
Neutral
ROC
5.09
Buy
Vertex Pharmaceuticals’s (VX1) Relative Strength Index (RSI) is 54.01, creating a Neutral signal.
Vertex Pharmaceuticals’s (VX1) Trend Strength Indicator (ADX) is 13.81, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) Commodity Channel Index (CCI) is 41.07, creating a Neutral signal.
Vertex Pharmaceuticals’s (VX1) Price Rate of Change (ROC) is 5.09, creating a Buy signal.

FAQ

Is VX1 a Buy, Hold, or Sell?
Based on VX1’s technical indicators, VX1 is a Buy.
    What is VX1’s RSI (14)?
    VX1’s RSI (14) is 54.01, which suggests VX1 is a Neutral.
      What is VX1’s MACD?
      VX1’s MACD is 4.41, which suggests VX1 is a Sell.
        What is VX1’s 5-day moving average?
        VX1’s 5-day moving average is 410.79, which suggests VX1 is a Sell.
          What is VX1’s 20-day moving average?
          VX1 20-day moving average is 404.49, which suggests VX1 is a Buy.
            What is VX1’s 50-day moving average?
            VX1’s 50-day moving average is 397.80, which suggests VX1 is a Buy.
              What is VX1’s 200-day moving average?
              VX1’s 200-day moving average is 375.01, which suggests VX1 is a Buy.
                What is VX1’s Williams % R (14)?
                VX1’s Williams % R (14) is -42.49, which suggests VX1 is a Buy.
                  What is VX1’s CCI (14)?
                  VX1’s CCI (14) is 41.07, which suggests VX1 is a Neutral.
                    What is the share price of Vertex Pharmaceuticals?